Premier Alternatives

XII Medical

Union City, CA · Founded 2017 · Privately Held (backing)

Developer of an implantable neurostimulation device designed to alleviate sleep apnea. XII Medical is based in Union City, CA and was founded in 2017. Its last known valuation is $117 million. It has raised $82.6 million across 3 recorded rounds; the latest was a $22.5 million early-stage round in Aug 2024.

Last price · $/share
—
Implied valuation
$117.0M
Total raised
$82.6M
Last round
Early Stage VC
Aug 2024

XII Medical key facts

  • Developer of an implantable neurostimulation device designed to alleviate sleep apnea.
  • XII Medical’s last known valuation is $117.0M.
  • It has raised $82.6M across 3 recorded rounds; the latest was Early Stage VC ($22.5M) in Aug 2024.
  • Notable investors include JobsOhio Ventures, Omega Funds, CincyTech, Ohio Department of Development, Ajax Health — 10 tracked in total.
  • XII Medical has filed 3 Form Ds with the SEC since 2022, most recently Aug 2024 ($22.5M sold to 11 investors).
  • Status: Privately Held (backing).
Free account
More of XII Medical with a free account
  • ·Watch XII Medical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

XII Medical funding rounds

3 rounds
Aug 2024Early Stage VC$22.5MSEC filing▮
Apr 2022Early Stage VC$7.5MSEC filing▮
Dec 2020Early Stage VC$15.1MSEC filing▮
Full funding history →

XII Medical valuation

XII Medical's last known valuation is $117 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How much has XII Medical raised?

XII Medical has raised $82.6 million across 3 recorded rounds since 2020. The largest was a $7.5 million early-stage round in Apr 2022; the most recent was a $22.5 million early-stage round in Aug 2024.

XII Medical has filed 3 Form Ds with the SEC since 2022, most recently in Aug 2024 ($22.5 million sold to 11 investors).

XII Medical investors

10 investors are on record for XII Medical, including JobsOhio Ventures, Omega Funds, CincyTech and Ohio Department of Development. The early-stage round in Aug 2024 drew 11 investors.

About XII Medical

Developer of an implantable neurostimulation device designed to alleviate sleep apnea. The company develops a minimally invasive outpatient technology that does not allow the muscles in the throat to temporarily relax, and avoids blockage of the airway during sleep, enabling patients to proactively increase oropharyngeal airflow.

Sector
Healthcare
HQ
Union City, CA, United States
Founded
2017
Employees
36
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.

Valuation on record
$117.0M

XII Medical’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.